Trial
NCT04632940
Phase 3 Trial of Pamrevlumab or Placebo in Combination With Systemic Corticosteroids in Participants With Ambulatory DMD
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Kyntra Bio
Collaborators
—
Condition
Duchenne Muscular Dystrophy
Intervention
Pamrevlumab
Why stopped
Study did not meet its primary endpoint.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-08-26